Skip to main navigation
logo

Quarterly Results

Show all

2020

Q3
  • PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
  • Form 10-Q

Site - Investor Tools

  • Print
  • Email Alerts
  • RSS Feeds
  • Contact IR
  • Email Page
  • Overview
  • Press Releases
  • Events & Presentations
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
  • Corporate Governance
    • Governance Overview
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
  • Shareholder Services
    • FAQ
    • Email Alerts
    • Contact IR
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • p53 Overview
    • p53 and Cancer
    • Drug Discovery
  • Pipeline
    • PMV Pipeline
    • PC14586
    • Clinical Trials
    • Access to Investigational Product
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
    • Corporate Governance
    • Stock Information
    • Shareholder Services
  • Life at PMV
    • Working at PMV
    • Job Opportunities
  • Contact

Site - Mobile

  • Home
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • p53 Overview
    • p53 and Cancer
    • Drug Discovery
  • Pipeline
    • PMV Pipeline
    • PC14586
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
      • SEC Filings
      • Quarterly Results
    • Corporate Governance
      • Governance Overview
      • Committee Composition
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
    • Shareholder Services
      • FAQ
      • Email Alerts
      • Contact IR
  • Life at PMV
    • Working at PMV
    • Job Opportunities
  • Contact
  • Terms of Use
  • Privacy Policy

logo

© 2021 PMV Pharmaceuticals, Inc. All rights reserved
  • Terms of Use
  • Privacy Policy